Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
Sales | 5,760,500 | 5,191,700 | 5,404,800 | 4,865,100 | 5,375,599 |
Cost of Goods | 1,521,200 | 1,400,900 | 1,465,000 | 1,323,000 | 1,389,200 |
Gross Profit | 4,239,300 | 3,790,800 | 3,939,800 | 3,542,100 | 3,986,400 |
Operating Expenses | 3,560,900 | 2,848,200 | 3,016,500 | 2,826,300 | 3,659,099 |
Operating Income | 678,599 | 943,500 | 923,300 | 715,800 | 327,500 |
Other Income | 213,401 | 27,200 | 21,200 | -149,000 | 117,101 |
Pre-tax Income | 892,000 | 970,700 | 944,500 | 566,800 | 444,600 |
Income Tax | 120,200 | 192,700 | 196,800 | 126,700 | -33,800 |
Net Income Continuous | 771,800 | 778,000 | 747,700 | 440,100 | 478,400 |
Net Income | $771,800 | $778,000 | $747,700 | $440,100 | $478,400 |
EPS Basic Total Ops | 0.72 | 0.74 | 0.71 | 0.42 | 0.45 |
EPS Basic Continuous Ops | 0.73 | 0.74 | 0.71 | 0.42 | 0.45 |
EPS Diluted Total Ops | 0.73 | 0.73 | 0.71 | 0.41 | 0.45 |
EPS Diluted Continuous Ops | 0.73 | 0.73 | 0.71 | 0.41 | 0.45 |
EBITDA(a) | $1,023,199 | $1,336,300 | $1,297,000 | $1,101,300 | $670,900 |